These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27235861)

  • 1. Vascular disrupting activity of combretastatin analogues.
    Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
    Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis.
    Porcù E; Viola G; Bortolozzi R; Persano L; Mitola S; Ronca R; Presta M; Romagnoli R; Baraldi PG; Basso G
    Angiogenesis; 2013 Jul; 16(3):647-62. PubMed ID: 23456551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation.
    Porcù E; Persano L; Ronca R; Mitola S; Bortolozzi R; Romagnoli R; Oliva P; Basso G; Viola G
    Sci Rep; 2016 Jun; 6():27886. PubMed ID: 27292568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.
    Ren X; Dai M; Lin LP; Li PK; Ding J
    Br J Pharmacol; 2009 Apr; 156(8):1228-38. PubMed ID: 19302593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tubulin antagonist pretubulysin displays antivascular properties in vitro and in vivo.
    Kretzschmann VK; Gellrich D; Ullrich A; Zahler S; Vollmar AM; Kazmaier U; Fürst R
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):294-303. PubMed ID: 24285578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and anti-vascular activity evaluation of ethoxy-erianin phosphate as a vascular disrupting agent.
    Yuan W; Su C; Yang X; Li Y; Cao Y; Liang X; Liu J
    J Cell Biochem; 2019 Oct; 120(10):16978-16989. PubMed ID: 31111562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis inhibition by the maleimide-based small molecule GNX-686.
    Nowak-Sliwinska P; Storto M; Cataudella T; Ballini JP; Gatz R; Giorgio M; van den Bergh H; Plyte S; Wagnières G
    Microvasc Res; 2012 Mar; 83(2):105-10. PubMed ID: 22056402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
    Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
    Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis.
    Xiao L; Yang S; Hao J; Yuan X; Luo W; Jiang L; Hu Y; Fu Z; Zhang Y; Zou C
    Cancer Lett; 2015 Apr; 359(1):148-54. PubMed ID: 25597785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
    Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
    J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.
    Palanisamy K; Nareshkumar RN; Sivagurunathan S; Raman R; Sulochana KN; Chidambaram S
    Microvasc Res; 2019 Mar; 122():136-145. PubMed ID: 30144414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
    Wang J; Yang Z; Wen J; Ma F; Wang F; Yu K; Tang M; Wu W; Dong Y; Cheng X; Nie C; Chen L
    J Pharmacol Sci; 2014; 126(3):198-207. PubMed ID: 25341684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W; Jin K; Lan H; Han N; Cao F; Teng L
    Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
    J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.
    Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY
    Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.